Bank Of New York Mellon Corp Esperion Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$1.46 - $7.3 $416,012 - $2.08 Million	284,940 New	284,940 $453 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $1.46 Million - $2.43 Million	286,286 New	286,286 $1.78 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $170,132 - $253,794	31,217 Added 12.94%	272,406 $1.83 Million
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $80,932 - $113,169	16,967 Added 7.57%	241,189 $1.53 Million
Q1 2022 May 11, 2022	BUY	$3.34 - $5.56 $377,065 - $627,690	112,894 Added 101.41%	224,222 $1.04 Million
Q4 2021 Feb 11, 2022	BUY	$4.81 - $11.92 $92,731 - $229,805	19,279 Added 20.94%	111,328 $557,000
Q3 2021 Nov 12, 2021	BUY	$11.34 - $21.37 $94,031 - $177,200	8,292 Added 9.9%	92,049 $1.11 Million
Q2 2021 Aug 11, 2021	SELL	$19.4 - $28.71 $340,179 - $503,429	-17,535 Reduced 17.31%	83,757 $1.77 Million
Q1 2021 May 13, 2021	SELL	$25.12 - $36.89 $420,132 - $616,985	-16,725 Reduced 14.17%	101,292 $2.84 Million
Q4 2020 Feb 09, 2021	SELL	$24.2 - $35.76 $436,955 - $645,682	-18,056 Reduced 13.27%	118,017 $3.07 Million
Q3 2020 Nov 12, 2020	SELL	$31.18 - $52.71 $43,839 - $74,110	-1,406 Reduced 1.02%	136,073 $5.06 Million
Q2 2020 Aug 12, 2020	BUY	$30.04 - $51.31 $7,209 - $12,314	240 Added 0.17%	137,479 $7.05 Million
Q1 2020 May 06, 2020	SELL	$27.44 - $73.84 $425,676 - $1.15 Million	-15,513 Reduced 10.16%	137,239 $4.33 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $1.79 Million - $3.03 Million	50,621 Added 49.56%	152,752 $9.11 Million
Q3 2019 Nov 07, 2019	SELL	$34.47 - $47.53 $72,938 - $100,573	-2,116 Reduced 2.03%	102,131 $3.74 Million
Q2 2019 Aug 12, 2019	BUY	$40.1 - $52.33 $44,671 - $58,295	1,114 Added 1.08%	104,247 $4.85 Million
Q1 2019 May 14, 2019	SELL	$40.11 - $53.57 $42,997 - $57,427	-1,072 Reduced 1.03%	103,133 $4.14 Million
Q4 2018 Feb 11, 2019	SELL	$36.99 - $59.11 $502,731 - $803,364	-13,591 Reduced 11.54%	104,205 $4.79 Million
Q3 2018 Nov 09, 2018	BUY	$40.74 - $51.41 $253,076 - $319,358	6,212 Added 5.57%	117,796 $0
Q2 2018 Aug 06, 2018	SELL	$36.2 - $76.4 $1.1 Million - $2.32 Million	-30,335 Reduced 21.37%	111,584 $4.37 Million
Q1 2018 May 15, 2018	BUY	$65.94 - $80.76 $1.69 Million - $2.08 Million	25,695 Added 22.11%	141,919 $10.3 Million
Q4 2017 Feb 09, 2018	BUY	$43.47 - $67.43 $5.05 Million - $7.84 Million	116,224	116,224 $7.65 Million

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account